Applied Pharmaceutical Nanotechnology 2019
October 25, 2019
Pfizer
1 Portland Street
Cambridge, MA 02139
Plenary Speakers for APN 2019
 |
Greg Troiano, MSE, Vice President of Technology and Chief Engineer, Seer, Inc. Biomolecular Biosensors for Health Monitoring and Disease Detection - An Update |
|
 |
Ulrich van Andrian, M.D., Ph.D. Mallinckrodt Professor of Immunopathology, Harvard Medical School Title TBA |
Confirmed Speakers for APN 2019
|
Gilles Besin, PhD, Sr. Director, Immunology, Moderna Therapeutics Title TBA |
||
 |
Richard Huang, PhD, Senior Director, L.E.A.F. Pharmaceuticals Title TBA |
|
|
Clarice Hutchens, PhD, Senior Director, Pfizer Title TBA |
||
 |
Hakho Lee, Ph.D., Associate Professor, Harvard Medical School Title TBA |
|
 |
Christopher Locher, Ph.D., CEO and Founder, Versatope Therapeutics Title TBA |
|
|
Young-Ho Song, Pfizer Title TBA |
||
 |
Gokul Swaminathan, PhD, Associate Principal Scientist, Merck Exploratory Science Center, Merck Research Laboratories Novel Immuno-Modulatory Lipid Nanoparticle Formulations for Vaccines and Immuno-Oncology Applications |
|
 |
Shraddha Thakkar, PhD, Principal Investigator, U.S. FDA Title TBA |
Proposed Sessions for 2019:
Session I: Particle Technology : Early and Late Stage Technology
Session II: Impact of Biology and Immunology in Nanotechnology
Session III: Regulatory Aspects of Nanotechnology
Please Join our Linkedin Group
